Skip to content

Effectiveness of Dry Needling and STM on Pain Management for Anterior Cruciate Ligament Reconstruction (ACLR)

The Effectiveness of Dry Needling and Soft Tissue Mobilization in the Management of Pain Post Anterior Cruciate Ligament (ACL) Reconstruction: A Randomized Controlled Trial

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03506685
Enrollment
0
Registered
2018-04-24
Start date
2018-06-01
Completion date
2019-06-01
Last updated
2025-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain and Anterior Cruciate Ligament Reconstruction

Keywords

dry needling, ACL reconstruction, knee ROM, pain management, opioid use

Brief summary

The purpose of this study is to determine if dry needling (DN) and soft tissue mobilization (STM) is superior to standard treatment protocol for affecting pain, pain medication usage and measurements of range of motion (ROM) after ACL reconstruction surgery compared to a standard treatment protocol. Measurements of pain, pain medication usage, lower extremity functional scale (LEFS) and ROM will be taken day 2 post op and 1 week, 2 weeks, 3 weeks, and 4 weeks post op. It is hypothesized that the inclusion of DN and STM will acutely decrease the demand for pain medication and improve objective measurements when compared to a standard treatment protocol. Findings will potentially lead to insights as to the benefit of applying these interventions to help decrease the demand for pain medication post-surgery.

Interventions

OTHERDry needling and STM

dry needling and soft tissue mobilization

Sponsors

Keller Army Community Hospital
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

2x5 mixed model anova

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Age 18-40 Department of Defense( DOD) beneficiaries (17 if Cadet) * Scheduled for ACL Reconstruction Surgery

Exclusion criteria

* Self-Reported Pregnancy * History of blood borne pathogens/infectious disease/active infection/metal allergy * Bleeding disorders or currently taking anti-coagulant medications * Participants who are not fluent in English

Design outcomes

Primary

MeasureTime frameDescription
Numerical pain rating scalechange from baseline, 2 days post-op, 1 week, 2 week, 3 week, 4 weekvalidated outcome measure for pain ranging from 0-10

Secondary

MeasureTime frameDescription
Lower extremity functional scalechange from baseline, 2 days post-op, 1 week, 2 week, 3 week, 4 weekvalidated measure to assess disability and function for the lower extremity on a scale of 0-80
Global rate of changechange from baseline, 2 days post-op, 1 week, 2 week, 3 week, 4 weekvalidated measure of self reported overall change in injury or condition ranging from -7 to 7
knee range of motionchange from baseline, 2 days post-op, 1 week, 2 week, 3 week, 4 weekmeasured with goniometer

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026